ApprovalTrail

Medical device licence · 111012 · Class 2

REBYOTA ADMINISTRATION SET

Yes: licensed in Canada

Licence status Issued (active); first licensed March 27, 2024. It is in Health Canada’s list of active licences.
Licence number
111012
Licence holder
Ferring Pharmaceuticals AKastrup, Denmark
Risk class
Class II (low to moderate risk)
Licence type
Single Device
First licensed
March 27, 2024
Devices covered
1

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • REBYOTA ADMINISTRATION SET

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.